Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. From Wikipedia
The pharmaceutical giant beat revenue and earnings estimates, yet its stock remains flat as challenges loom in 2025.
